Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Zhengye Biotechnology FY EPS $0.03, Sales $25.531M

Author: Benzinga Newsdesk | July 03, 2025 08:33am
Zhengye Biotechnology (NASDAQ:ZYBT) reported quarterly earnings of $0.03 per share. The company reported $25.531 million in sales this quarter.

Posted In: ZYBT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist